INDIANAPOLIS -- A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas ...

Time for a rear-ality check. Colorectal cancer rates have been rising among adults younger than 50 since the 1990s, a troubling trend that has perplexed scientists. Because of the increase in cases, ...

Automatically mailing a stool test kit to people's homes might be the best way to boost colon cancer screening among younger adults, a new study says. More 45- to 49-year-olds went ahead with cancer ...

Colorectal cancer is one of the leading causes of cancer deaths worldwide. Until now, colonoscopy has been the most reliable test, but many people avoid it because it is invasive, expensive, and ...

Novel first-generation cell-free DNA blood (cf-bDNA) tests for colorectal cancer (CRC) cost more and are less effective than colonoscopy or stool tests, a new analysis suggests. Researchers estimated ...

Stool tests, often perceived as routine or unimportant, are powerful diagnostic tools capable of identifying a range of serious gastrointestinal diseases. From detecting colorectal cancer (CRC) at ...

Geneoscopy is poised to commercialize Colosense, its noninvasive, at-home multitarget stool RNA test for colorectal cancer screening. In 2025, the St. Louis, MO-based life sciences company focused on ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...